Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit

Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battle Johnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby ⁠powder and other talc products caused ⁠ovarian cancer , in a landmark ​deal that could end a contentious, decade-long legal battle. Johnson & Johnson on Monday said the settlement covers about 76,000 claims, including ones consolidated in a federal court in New Jersey, and related cases in state court, ⁠representing nearly all of the remaining talc claims against the company. Cont

This story was reported by Business | The Guardian. EUROPES curates Europe's most relevant coverage — read the full report at the original source.